Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released May 5, 2020, before the open
10-Q filed May 8, 2020, 38 days after period end · 0001171843-20-003556
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $23.77M | $28.20M | $26.76M | $18.09M |
| Net Income | -$4.52M | -$2.37M | -$4.06M | -$1.07M |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.12 |
| -$0.06 |
| -$0.11 |
| -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
